Ryan D. Chow

University of California, Irvine — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

27h-index3.6kcitations117works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CRISPR and Genetic Engineering(22), Cancer Immunotherapy and Biomarkers(18), Cancer Genomics and Diagnostics(17), CAR-T cell therapy research(17), SARS-CoV-2 and COVID-19 Research(13)

Publications117 total

Supplementary Figures from Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti–PD-1 Immunotherapy in Endometrial Carcinoma
2025Open Access
Table S2 from Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti–PD-1 Immunotherapy in Endometrial Carcinoma
2025Open Access
Table S3 from Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti–PD-1 Immunotherapy in Endometrial Carcinoma
2025Open Access
Table S4 from Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti–PD-1 Immunotherapy in Endometrial Carcinoma
2025Open Access
Table S1 from Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti–PD-1 Immunotherapy in Endometrial Carcinoma
2025Open Access
Outcomes of enfortumab vedotin plus pembrolizumab in patients with advanced urothelial cancer and severe renal dysfunction
Urologic Oncology Seminars and Original Investigations·2025· 1 citedOpen Access
Brain-wide Genome Editing via STEP-RNPs for Treatment of Angelman Syndrome
2025Open Access
Reduced-Dose Enfortumab Vedotin, Treatment Continuity, and Survival in Urothelial Cancer
JAMA Oncology·2025· 1 citedOpen Access
Artificial intelligence-, organoid-, and organ-on-chip-powered models to improve pre-clinical animal testing of vaccines and immunotherapeutics: potential, progress, and challenges
Frontiers in Artificial Intelligence·2025· 1 citedOpen Access
The Path Towards Effective Long-Lasting Tissue-Targeted Prime/Pull/Keep Herpes Simplex Therapeutic Vaccines
Vaccines·2025· 3 citedOpen Access
Association Between Early on-Treatment Weight Loss With Enfortumab Vedotin Plus Pembrolizumab and Survival in Advanced Urothelial Carcinoma
Clinical Genitourinary Cancer·2025Open Access
Assessment of synergistic vs. independent drug activity for enfortumab vedotin and pembrolizumab in untreated advanced urothelial carcinoma
Urologic Oncology Seminars and Original Investigations·2025· 2 citedOpen Access
Age-Related Impairment of Innate and Adaptive Immune Responses Exacerbates Herpes Simplex Viral Infection
Pathogens·2025· 3 citedOpen Access
Abstract LB434: Discovery and preclinical evaluation of ATM-5292: A potent and selective RNA targeting splice modulator for the treatment of non small cell lung cancer (NSCLC) and breast cancer, enabled by the PARSE™ machine learning platform
Cancer Research·2025
Th1 cells express Tfh effector molecules and associate with B cells at the T-B border following viral infection
2025· 3 citedOpen Access
Cas12a-knock-in mice for multiplexed genome editing, disease modelling and immune-cell engineering
Nature Biomedical Engineering·2025· 18 citedOpen Access
Persistent postremission clonal hematopoiesis shapes the relapse trajectories of acute myeloid leukemia
Blood Advances·2025· 6 citedOpen Access
Author Correction: Multiplexed inhibition of immunosuppressive genes with Cas13d for combinatorial cancer immunotherapy
Nature Biotechnology·2025Open Access
Abstract A021: Evolutionary trajectories and single cell methylation analysis of DNMT3A and TET2 mutant acute myeloid leukemia
Cancer Research·2025
Multiplexed inhibition of immunosuppressive genes with Cas13d for combinatorial cancer immunotherapy
Nature Biotechnology·2025· 12 cited
page 1 of 6Next →

Frequent Co-authors

Sidi Chen(32), Matthew B. Dong(15), Lupeng Ye(14), Guangchuan Wang(11), Paul Renauer(10), Craig B. Wilen(10), Xiaoyun Dai(9), Jennifer Chen(9), Jonathan J. Park(8), Youssef Errami(8), Jin Wei(8), Lei Peng(7), Yueqi Zhang(7), Medha Majety(7), Stanley Z. Lam(6), Mia Madel Alfajaro(6), Renata B. Filler(6), Akiko Iwasaki(6), Eric Song(6), Yaying Du(5)